Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD

OBJECTIVE: To investigate whether aquaporin-4–immunoglobulin G (AQP4-IgG) titers and measures of complement-mediated cell killing are clinically useful to predict the occurrence of relapse, relapse severity, and/or disability in neuromyelitis optica spectrum disorder (NMOSD). METHODS: We studied 336...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neurol Neuroimmunol Neuroinflamm
Auteurs principaux: Jitprapaikulsan, Jiraporn, Fryer, James P., Majed, Masoud, Smith, Carin Y., Jenkins, Sarah M., Cabre, Philippe, Hinson, Shannon R., Weinshenker, Brian G., Mandrekar, Jay, Chen, John J., Lucchinetti, Claudia F., Jiao, Yujuan, Segan, Jessica, Schmeling, John E., Mills, John, Flanagan, Eoin P., McKeon, Andrew, Pittock, Sean J.
Format: Artigo
Langue:Inglês
Publié: Lippincott Williams & Wilkins 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7286655/
https://ncbi.nlm.nih.gov/pubmed/35413004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000727
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires